Nationality Israeli | Name Erez Vigodman | |
 | ||
Occupation CEO, Teva Pharmaceutical Industries | ||
TEVA Pharmaceutical Industries Limited Visits the NYSE
Erez Vigodman (Hebrew: ארז ויגודמן; born 1959) is an Israeli businessman, the former president and CEO of Teva Pharmaceutical Industries, the largest generic drug manufacturer in the world.
Contents
Career
Vigodman served as the CEO of Makhteshim Agan until joining Teva, and was president and CEO of Strauss Group prior to this.
In January 2014, Vigodman, replaced Eyal Desheh as the CEO of Teva, with Desheh returning to his role as CFO.
In February 2017, Teva announced that Vigodman was stepping down as CEO with immediate effect and would be replace on an interim basis by the chairman, Yitzhak Peterburg, and Sol Barer would be the new chairman. This was a consequence of the $40 billion acquisition of Activis' generics division, which sent Teva spiralling down and saw its market capitalisation cut in half in less than a year. A successor was not immediately found.
